Sec. 10.52.01.07. Monitoring and Evaluation  


Latest version.
  • A. OADPO programs shall:

    (1) Submit all data for each reporting period on a quarterly basis as required by the Department, including:

    (a) The number of:

    (i) Participants served by the OADPO program;

    (ii) New participants registered by the OADPO program;

    (b) Demographic data of participants served by the OADPO program, including:

    (i) Age;

    (ii) Gender identity;

    (iii) Sexual orientation;

    (iv) Race;

    (v) Ethnicity;

    (vi) Zip code; and

    (vii) Types of drugs the participant reports using;

    (c) The number of hypodermic needles and syringes distributed and collected;

    (d) Each location where hypodermic needles and syringes were distributed; and

    (e) The number of referrals to services provided to participants listed in Health-General Article, §24-903(A)(6), Annotated Code of Maryland, and Regulation .05A(4) of this chapter; and

    (2) Collect data using methods that will not deter participants from utilizing OADPO program services.

    B. The Department may conduct site visits to monitor and evaluate an OADPO program.